Katrina M. Whyman, MS Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 141 Etta Frasier Dr, Windsor, VT 05089 Phone: 802-674-9400 |
Ashley Hutton, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 141 Etta Frasier Dr, Windsor, VT 05089 Phone: 802-674-9400 |
Elizabeth P. Smith, MSW LICSW Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 77 Weston Hts, Windsor, VT 05089 Phone: 802-345-9903 |
Timothy Richard Hebert, M.S., L.A.D.C. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 289 County Rd, Windsor, VT 05089 Phone: 802-674-7041 |
Heather Findlay, LCMHC, MA Counselor - Professional Medicare: Medicare Enrolled Practice Location: 841 Us Route 5 N, Windsor, VT 05089 Phone: 802-230-6480 |
Erica M Mullane, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7 Everett Ln, Windsor, VT 05089 Phone: 802-373-6617 |
News Archive
The Neonatal Intensive Care Unit (NICU) at MedStar Washington Hospital Center recently celebrated a major safety milestone: two years without a single Central Line-Associated Bloodstream Infection (CLABSI) in its smallest and most vulnerable babies.
His State Of The Union comments will likely highlight the different partisan views on how these automatic spending cuts, set to kick in March 1, could be minimized. Republicans continue to press for changes in entitlement programs, such as Medicare.
Professor Robert Sinclair at the Okinawa Institute of Science and Technology Graduate University and Professor Dennis Bamford and Dr. Janne Ravantti from the University of Helsinki have found new evidence to support a classification system for viruses based on viral structure.
Zambia recently launched a four-year project to improve tuberculosis diagnosis and ensure early treatment for the disease, the Daily Mail reports.
Ibrutinib is a drug for the treatment of rare diseases. It has been approved for the treatment of adults with chronic lymphocytic leukaemia (CLL) or with relapsed or refractory mantle cell lymphoma (MCL) since 2014, and since 2015 also for the treatment of adults with Waldenström macroglobulinaemia. Regarding the treatment of patients with CLL or MCL, the Federal Joint Committee (G-BA) already conducted a benefit assessment and made a decision in 2015.
› Verified 7 days ago